Contact Us marketing@medicilon.com
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
SERVICES
SERVICES
01 Drug Discovery
Chemistry Research Biology Research Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates Active Pharmaceutical Ingredients Pharmaceutical preparation Analytical Method Development and Quality Control CMC Filings Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics Drug Safety Evaluation DMPK Bioanalysis IND Filings
PLATFORM
PLATFORM
01 One-stop Integrated Services
Liposome Drug Development Drug Discovery Pharmaceutical Research Preclinical Research Botanical Drug Preclinical R&D
02 Innovative Drug R&D Services
Peptide Drug Conjugate (PDC) Antibody Nucleic Acid Drug Cellular Immunotherapies mRNA Vaccine PROTAC ADC
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection Metabolite Identification (MetID) Drug Forming Research Flow Cytometry Technology SEND Format Conversion Flow Sorting NanoString nCounter Detection Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
Rodent Cerebrovascular Disease Inflammatory and Immune Diseases IO Pharmacodynamic Model
05 High-end Preparations Technology Platform
Skin Topical Preparation Ophthalmic drug Inhalation drug
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service KRAS-targeted Drugs R&D Service GLP-1 New Drug R&D Service
07 Safety Assessment Lab of Process Chemistry

08 Public Services
CAREERS
Talent Development
Campus Recruitment
Recruitment
NEWS
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
INVESTORS
Stock Information
Investment Contact
CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
CN
×
中
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Jul 13,2020
Chemical FTE Service
Medicilon's chemical department has comprehensive chemical research capabilities and facilities including medicinal chemistry, synthetic chemistry, process research and analytical support, and professional synthetic technology. It has a good record of project advancement and the generation of preclinical drug candidates. We can quickly complete new drug development projects from compound screening to new drug clinical researchRead more
More
Chemical FTE Service
Jul 10,2020
Antibody Preparation Service Company
Antibody preparation service According to the principles and methods of preparation, antibody preparation services can be divided into three categories: polyclonal antibodies, monoclonal antibodies, and genetically engineered antibodies. Polyclonal antibody preparation: Medicilon polyclonal antibody preparation service has professional antibody preparation personnel, advanced antibody preparation and production equipment, and the introduction of advanced preparation technology. MedicilonRead more
More
Jul 08,2020
Chemical synthesized peptide drugs
Company Profile: Medicilon's peptide synthesis research team is closely focused on the topic of peptide drug research and is committed to solving the core problems that limit the development and application of peptide drugs. To improve the downstream peptide drug signal transduction pathways and mechanisms of action to improve the system. Through multi-disciplinary cooperation andRead more
More
Chemical synthesized peptide drugs
Jul 08,2020
Monoclonal antibody preparation technology
Service background Monoclonal antibody (McAb) uses lymphocyte hybridoma technology to fuse immunized animal B lymphocytes and myeloma cells to form hybridoma cells. Through HAT screening, ELISA antibody detection, and subcloning, the antibody secreting function can be selected and can be propagated indefinitely. Hybridoma cells, producing monoclonal antibodies. The advantages of monoclonal antibodies are specificity, uniformity,Read more
More
Monoclonal antibody preparation technology
Jul 08,2020
Breakthrough|non-human primate new crown model
Due to the rapid increase in new cases, the 2019 Coronavirus Disease (COVID-19) quickly attracted global attention, and the pathogen was identified as SARS-CoV-2. As of now (July 7), according to real-time statistics released by Johns Hopkins University, there have been more than 11.74 million confirmed cases of new coronary pneumonia worldwide and 540,000 deaths.Read more
More
Jul 06,2020
Polyclonal antibody preparation process
principle Antibody: An important effector molecule that mediates humoral immunity. It is a type of immunoglobulin that is synthesized and secreted by B cells that proliferate and differentiate into plasma cells after being activated by antigen. Clone: ​​refers to asexual reproduction cell line, which is a cluster of pure cells formed by the division andRead more
More
Polyclonal antibody preparation process
Jul 05,2020
Medicilon Tumor Modeling Service
Animal tumor models are an important scientific research project to study human tumors. Medicilon provides various effective animal models according to customer needs to test the effectiveness of drugs. Experimental animals include non-human primates, dogs, mice, rats, rabbits, guinea pigs, and nude mice. At present, we have established a number of effective animal tumor models,Read more
More
Medicilon Tumor Modeling Service
Jul 03,2020
Acute Toxicity Test of Chemical Drugs
Medicilon's acute toxicology test is based on the knowledge of the test substance, following the principle of "specific analysis of specific problems", and selecting a reasonable test method according to the structural characteristics, physicochemical properties, indication characteristics and test purpose of the compound , Design an appropriate test plan, and combine other pharmacological and toxicologicalRead more
More
Acute Toxicity Test of Chemical Drugs
Jul 01,2020
Medicilon Human Disease Animal Model
Medicilon provides various effective animal models according to customer needs to test the effectiveness of drugs. Experimental animals include non-human primates, dogs, mice, rats, rabbits, and guinea pigs. At present, we have established a number of effective animal models, and have passed multiple verifications and long-term practical tests. At the same time, our employees' richRead more
More
Medicilon Human Disease Animal Model
Jul 01,2020
Drug Safety Evaluation Center
Drug Safety Evaluation Center The drug safety evaluation package research data provided by Medicilon puya was reported to CFDA, the US FDA, and the Australian TGA 15 times for Investigational New Drug (IND for short). , Australia TGA declared Investigational New Drug (IND) more than 60 times. "Medicilon Drug Safety Evaluation Service Project” Drug SafetyRead more
More
Drug Safety Evaluation Center
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(781)535-1428(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->